51: Lipid Lowering Therapy Flashcards

1
Q

What are the two main types of plasma lipid?

A

Cholesterol and triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do lipids travel in the body?

A

Via lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When do you use lipid lowering therapy in primary prevention? secondary prevention?

A

Primary - CVS risk > 30% 10 years

Secondary - angina, MI, CVA, PVD, diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the current target LDL?

A

< 1.8mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 2 most commonly used statins in NZ?

A

Atorvastatin and simvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of statins?

A

Competitively inhibit HMG CoA reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where are the pleotropic effects of statins though to come from?

A

Blockage of isoprenoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most commonly used fibrate in NZ?

A

Benzafibrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical indications for fibrate use?

A
  • Isolated hypertriglycerideaemia

- Combined therapy with statins for resistant hypercholesterolaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

____ is a new agent used in combination therapy with statins

A

Ezetimibe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the clinical use of nicotinic acid (B3)?

A
  • Very rarely used in isolation

- Used to reduce triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do new drugs like evolocumab and inclisiran target?

A
  • PSCK
  • Protease that binds to LDL receptors on hepatocyte
  • Causes their endocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly